Motif Bio meeting with U.S. FDA held as planned

Medigene AG: Medigene presented data on favorable safety pattern of PRAME-specific TCR on neuronal cells at 2019 ASGCT Meeting

Motif Bio Signs Agreement with Lamellar Biomedical

Abivax Receives First Phase 2b Ulcerative Colitis Clinical Trial Authorization, Provides Update on Progress of ABX464 Clinical Development Plan in Inflammatory Diseases

Biom’up reports 2018 full-year results and provides a business update

Molecular Health präsentiert bei anstehenden Kongressen zu Herausforderungen der digitalisierten Medizin

Allergy Therapeutics plc: Regulatory and Trading Update

Notice of Annual General Meeting

Motif Bio Announces Appointment of Andrew Powell to Board of Directors

Expedeon Reports Financial Results for Fiscal Year 2018 – Financial Guidance Met